×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder
Become an Incathlab member and receive full access to its content!
You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.
Registration Login
Registration Login
16545 views
Case summary
Patient: male 77 y
Dyspnea and angina since several months
NSTEMI 26.11.16
3 vessels disease: several stenosis LAD, CX and RCA
culprit lesion LAD (with thrombus)
CTO IM branch und PD of RCA
Syntax score: 28
LVEF: 45%
Inferior and apikal akinesia
No valvular heart disease
Renal function: eGFR = 85 ml/min/1.73m2
CVRF: aHT, dysplidemia
How to treat this patient?
Syntax score: 28
EuroSCORE II: 2.2
STS-score: 1.2 for mortality
9.4 for morbiditiy and mortality
Proposed treatment: CABG, but patient refused
Todays planned procedures:
PCI of the LAD and diagonal branch
Ev. RCX PCI
Protocol
OptiRAY® (Ioversol)
Concentration 300 mgI/mL
Flow rate: 3.5 mL/ s
Volume: 112 mL
Total exposure : 0.8 Gy
Exposure time: 27 minutes
15 images / s low dose Philips
57 images mostly fluoro
Shooting date : 2016-11-03
Last update : 2021-06-09
Last update : 2021-06-09
OptiRAY® / Guerbet
Optiray® contrast agent is lower osmolar, lower viscosity and nonionic.
Join the Discussion
Suggestions
Wednesday, July 5th 2023 from 06pm to 07pm (GMT+2)
Honolulu : Wednesday, July 5th 2023 from 07am to 08am (GMT+2)
San Francisco : Wednesday, July 5th 2023 from 10am to 11am (GMT+2)
New York : Wednesday, July 5th 2023 from 01pm to 02pm (GMT+2)
Buenos Aires : Wednesday, July 5th 2023 from 02pm to 03pm (GMT+2)
Reykjavik : Wednesday, July 5th 2023 from 05pm to 06pm (GMT+2)
London / Dublin : Wednesday, July 5th 2023 from 06pm to 07pm (GMT+2)
Paris / Berlin : Wednesday, July 5th 2023 from 07pm to 08pm (GMT+2)
Istanbul : Wednesday, July 5th 2023 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Wednesday, July 5th 2023 from 09pm to 10pm (GMT+2)
Bangkok : Thursday, July 6th 2023 from 12am to 01am (GMT+2)
Shanghai : Thursday, July 6th 2023 from 01am to 02am (GMT+2)
Tokyo : Thursday, July 6th 2023 from 02am to 03am (GMT+2)
Sydney : Thursday, July 6th 2023 from 04am to 05am (GMT+2)
Wellington : Thursday, July 6th 2023 from 06am to 07am (GMT+2)
San Francisco : Wednesday, July 5th 2023 from 10am to 11am (GMT+2)
New York : Wednesday, July 5th 2023 from 01pm to 02pm (GMT+2)
Buenos Aires : Wednesday, July 5th 2023 from 02pm to 03pm (GMT+2)
Reykjavik : Wednesday, July 5th 2023 from 05pm to 06pm (GMT+2)
London / Dublin : Wednesday, July 5th 2023 from 06pm to 07pm (GMT+2)
Paris / Berlin : Wednesday, July 5th 2023 from 07pm to 08pm (GMT+2)
Istanbul : Wednesday, July 5th 2023 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Wednesday, July 5th 2023 from 09pm to 10pm (GMT+2)
Bangkok : Thursday, July 6th 2023 from 12am to 01am (GMT+2)
Shanghai : Thursday, July 6th 2023 from 01am to 02am (GMT+2)
Tokyo : Thursday, July 6th 2023 from 02am to 03am (GMT+2)
Sydney : Thursday, July 6th 2023 from 04am to 05am (GMT+2)
Wellington : Thursday, July 6th 2023 from 06am to 07am (GMT+2)
Left Main and Bifurcation treatment:
impact of clinical trials in daily practice
Share
May 2017
Honolulu : Tuesday, May 16th 2017 from 11:30pm to 12:30am (GMT+2)
San Francisco : Wednesday, May 17th 2017 from 02:30am to 03:30am (GMT+2)
New York : Wednesday, May 17th 2017 from 05:30am to 06:30am (GMT+2)
Buenos Aires : Wednesday, May 17th 2017 from 06:30am to 07:30am (GMT+2)
Reykjavik : Wednesday, May 17th 2017 from 09:30am to 10:30am (GMT+2)
London / Dublin : Wednesday, May 17th 2017 from 10:30am to 11:30am (GMT+2)
Paris / Berlin : Wednesday, May 17th 2017 from 11:30am to 12:30pm (GMT+2)
Istanbul : Wednesday, May 17th 2017 from 12:30pm to 01:30pm (GMT+2)
Moscou / Dubaï : Wednesday, May 17th 2017 from 01:30pm to 02:30pm (GMT+2)
Bangkok : Wednesday, May 17th 2017 from 04:30pm to 05:30pm (GMT+2)
Shanghai : Wednesday, May 17th 2017 from 05:30pm to 06:30pm (GMT+2)
Tokyo : Wednesday, May 17th 2017 from 06:30pm to 07:30pm (GMT+2)
Sydney : Wednesday, May 17th 2017 from 08:30pm to 09:30pm (GMT+2)
Wellington : Wednesday, May 17th 2017 from 10:30pm to 11:30pm (GMT+2)
San Francisco : Wednesday, May 17th 2017 from 02:30am to 03:30am (GMT+2)
New York : Wednesday, May 17th 2017 from 05:30am to 06:30am (GMT+2)
Buenos Aires : Wednesday, May 17th 2017 from 06:30am to 07:30am (GMT+2)
Reykjavik : Wednesday, May 17th 2017 from 09:30am to 10:30am (GMT+2)
London / Dublin : Wednesday, May 17th 2017 from 10:30am to 11:30am (GMT+2)
Paris / Berlin : Wednesday, May 17th 2017 from 11:30am to 12:30pm (GMT+2)
Istanbul : Wednesday, May 17th 2017 from 12:30pm to 01:30pm (GMT+2)
Moscou / Dubaï : Wednesday, May 17th 2017 from 01:30pm to 02:30pm (GMT+2)
Bangkok : Wednesday, May 17th 2017 from 04:30pm to 05:30pm (GMT+2)
Shanghai : Wednesday, May 17th 2017 from 05:30pm to 06:30pm (GMT+2)
Tokyo : Wednesday, May 17th 2017 from 06:30pm to 07:30pm (GMT+2)
Sydney : Wednesday, May 17th 2017 from 08:30pm to 09:30pm (GMT+2)
Wellington : Wednesday, May 17th 2017 from 10:30pm to 11:30pm (GMT+2)
Discussion around complex PCI
How to deal with complications?
Share
Monday, September 19th 2022 from 06pm to 07pm (GMT+2)
Honolulu : Monday, September 19th 2022 from 07am to 08am (GMT+2)
San Francisco : Monday, September 19th 2022 from 10am to 11am (GMT+2)
New York : Monday, September 19th 2022 from 01pm to 02pm (GMT+2)
Buenos Aires : Monday, September 19th 2022 from 02pm to 03pm (GMT+2)
Reykjavik : Monday, September 19th 2022 from 05pm to 06pm (GMT+2)
London / Dublin : Monday, September 19th 2022 from 06pm to 07pm (GMT+2)
Paris / Berlin : Monday, September 19th 2022 from 07pm to 08pm (GMT+2)
Istanbul : Monday, September 19th 2022 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Monday, September 19th 2022 from 09pm to 10pm (GMT+2)
Bangkok : Tuesday, September 20th 2022 from 12am to 01am (GMT+2)
Shanghai : Tuesday, September 20th 2022 from 01am to 02am (GMT+2)
Tokyo : Tuesday, September 20th 2022 from 02am to 03am (GMT+2)
Sydney : Tuesday, September 20th 2022 from 04am to 05am (GMT+2)
Wellington : Tuesday, September 20th 2022 from 06am to 07am (GMT+2)
San Francisco : Monday, September 19th 2022 from 10am to 11am (GMT+2)
New York : Monday, September 19th 2022 from 01pm to 02pm (GMT+2)
Buenos Aires : Monday, September 19th 2022 from 02pm to 03pm (GMT+2)
Reykjavik : Monday, September 19th 2022 from 05pm to 06pm (GMT+2)
London / Dublin : Monday, September 19th 2022 from 06pm to 07pm (GMT+2)
Paris / Berlin : Monday, September 19th 2022 from 07pm to 08pm (GMT+2)
Istanbul : Monday, September 19th 2022 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Monday, September 19th 2022 from 09pm to 10pm (GMT+2)
Bangkok : Tuesday, September 20th 2022 from 12am to 01am (GMT+2)
Shanghai : Tuesday, September 20th 2022 from 01am to 02am (GMT+2)
Tokyo : Tuesday, September 20th 2022 from 02am to 03am (GMT+2)
Sydney : Tuesday, September 20th 2022 from 04am to 05am (GMT+2)
Wellington : Tuesday, September 20th 2022 from 06am to 07am (GMT+2)
Benefits of Mechanical Circulatory Support devices
Swiss Case Club
Share
Friday, February 17th 2023 from 12:30pm to 02pm (GMT+1)
Honolulu : Friday, February 17th 2023 from 01:30am to 03am (GMT+1)
San Francisco : Friday, February 17th 2023 from 03:30am to 05am (GMT+1)
New York : Friday, February 17th 2023 from 06:30am to 08am (GMT+1)
Buenos Aires : Friday, February 17th 2023 from 08:30am to 10am (GMT+1)
London / Dublin : Friday, February 17th 2023 from 11:30am to 01pm (GMT+1)
Paris / Berlin : Friday, February 17th 2023 from 12:30pm to 02pm (GMT+1)
Istanbul : Friday, February 17th 2023 from 01:30pm to 03pm (GMT+1)
Moscou / Dubaï : Friday, February 17th 2023 from 03:30pm to 05pm (GMT+1)
Bangkok : Friday, February 17th 2023 from 06:30pm to 08pm (GMT+1)
Shanghai : Friday, February 17th 2023 from 07:30pm to 09pm (GMT+1)
Tokyo : Friday, February 17th 2023 from 08:30pm to 10pm (GMT+1)
Sydney : Friday, February 17th 2023 from 09:30pm to 11pm (GMT+1)
Wellington : Friday, February 17th 2023 from 11:30pm to 01am (GMT+1)
San Francisco : Friday, February 17th 2023 from 03:30am to 05am (GMT+1)
New York : Friday, February 17th 2023 from 06:30am to 08am (GMT+1)
Buenos Aires : Friday, February 17th 2023 from 08:30am to 10am (GMT+1)
London / Dublin : Friday, February 17th 2023 from 11:30am to 01pm (GMT+1)
Paris / Berlin : Friday, February 17th 2023 from 12:30pm to 02pm (GMT+1)
Istanbul : Friday, February 17th 2023 from 01:30pm to 03pm (GMT+1)
Moscou / Dubaï : Friday, February 17th 2023 from 03:30pm to 05pm (GMT+1)
Bangkok : Friday, February 17th 2023 from 06:30pm to 08pm (GMT+1)
Shanghai : Friday, February 17th 2023 from 07:30pm to 09pm (GMT+1)
Tokyo : Friday, February 17th 2023 from 08:30pm to 10pm (GMT+1)
Sydney : Friday, February 17th 2023 from 09:30pm to 11pm (GMT+1)
Wellington : Friday, February 17th 2023 from 11:30pm to 01am (GMT+1)
Coronary sinus reducer
Share
Alexander P. Why DES in distal LAD ? BVS Absorb?
Daniel W. Hi Alexander. Thank you for your question. We know from the Absorb data that scaffolds perform worse than DES in smaller vessels, associated with a higher MACE rate. An alternative could be treating small vessels with DCB. The BASKET small study result will be presented in 2018 (DES vs DCB in small vessels). DCB are good in our experience when you have TIMI flow III, no more than a dissection A or B, and less than 30% residual stenosis.